2160546-07-4
LACS-13909
1923844-48-7
Benzamide, 4-chloro-N-[(1R)-1-[cis-4-(6-fluoro-4-quinolinyl)cyclohexyl]ethyl]-
1622849-43-7
GSK3145095
2291164-02-6
GS-4361
2409963-83-1
2-Buten-1-amine, 3-fluoro-4-(8-quinolinylsulfonyl)-, (2Z)-
1192171-69-9
Vonafexor
2162982-11-6
BAY-218
1715025-32-3
ERK-IN-1
2102501-84-6
Ketohexokinase inhibitor 1
2173556-69-7
Carbamic acid, N-[5-[2-(acetylamino)-6-benzothiazolyl]-2-methyl-3-pyridinyl]-, cyclohexyl ester
2180127-82-4
BMS-615
1809885-32-2
EC-5026
1403859-14-2
CC-90001
2173134-00-2
vanin-1 inhibitor
2569009-58-9
Benzenesulfonamide, 2,6-dimethoxy-N-[4-methoxy-6-(1H-pyrazol-1-ylmethyl)-1,2-benzisoxazol-3-yl]-
1293281-49-8
Seltorexant
1933528-96-1
MDR652
2226735-55-1
GSK547
2101626-26-8
GSK2894631A
2266569-73-5
UMB298
More Information:
Check CAS No 1622849-43-7 on External Site
1622849-43-7
,1622849-43-7
2025-12-28 Discover GSK3145095 (CAS No: 1622849-43-7) and related compounds. Ideal for advanced chemical applications. Competitive pricing, fast delivery, and expert support worldwide.